Epidemiological Update: Occurrence of variants of SARS-CoV-2 in the Americas (20 January 2021)
Actualización Epidemiológica: ocurrencia de variantes de SARS-CoV-2 en las Américas (20 de enero del 2021)
Fecha
2021-01-20Metadatos
Mostrar el registro completo del ítemOtros idiomas
Resumen
The appearance of mutations is a natural and expected event within the evolution of the virus. Since the initial genomic characterization of SARS-CoV-2, the virus has been divided into different genetic groups or clades. In fact, some specific mutations define the viral genetic groups (also called lineages) that are currently circulating globally. La aparición de mutaciones es un evento natural y esperado dentro del proceso de evolución de los virus. Desde la caracterización genómica inicial del SARS-CoV-2, este virus se ha dividido en diferentes grupos genéticos o clados. De hecho, algunas mutaciones específicas definen los grupos genéticos virales (también denominados linajes) que circulan actualmente a nivel global.
Tema
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Regional Update, Influenza. Epidemiological Week 41 (26 October 2021)
(Washington, D.C., PAHO, 2021-10-26)[WEEKLY SUMMARY]. North America: Overall, influenza activity remained low. In Canada and Mexico respiratory syncytial virus (RSV) detections continued to increase and in the United States, RSV activity continues to decrease. ... -
Regional Update, Influenza. Epidemiological Week 28 (27 July 2022)
(Washington, D.C., PAHO, 2022-07-29)[WEEKLY SUMMARY]. North America: Overall, influenza activity decreased in the subregion while SARS-CoV-2 continued to rise. In Mexico, influenza activity with A(H3N2) virus predominance decreased, while SARS-CoV-2 positivity ... -
Regional Update, Influenza. Epidemiological Week 40 (19 October 2022)
(Washington, D.C., PAHO, 2022-10-19)[WEEKLY SUMMARY]. North America: Influenza activity remained low throughout the subregion. Influenza A(H3N2) predominated with the co-circulation of influenza A(H1N1)pdm09 and influenza B/Victoria. SARS‑CoV‑2 activity ...
